New Year Bumper Sale @ Rs. 1 X
Chlorpheniramine + Menthol + Phenylephrine + Ambroxol + Guaifenesin is an allopathic medicine The correct dosage of Chlorpheniramine + Menthol + Phenylephrine + Ambroxol + Guaifenesin depends on the patient's age, gender, and medical history. This information has been provided in detail in the dosage section.
Chlorpheniramine + Menthol + Phenylephrine + Ambroxol + Guaifenesin is used to treat the following -
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
13 - 18 years (Adolescent) |
|
Adult |
|
Geriatric |
|
Based on research, the following side effects have been observed when Chlorpheniramine + Menthol + Phenylephrine + Ambroxol + Guaifenesin is used -
Severe
Moderate
Mild
Common
Is the use of Chlorpheniramine + Menthol + Phenylephrine + Ambroxol + Guaifenesin safe for pregnant women?
Chlorpheniramine + Menthol + Phenylephrine + Ambroxol + Guaifenesin can cause unwanted side effects in pregnant women. If you experience any side effects, stop taking Chlorpheniramine + Menthol + Phenylephrine + Ambroxol + Guaifenesin right away. Take your doctor's advice before taking it again.
Is the use of Chlorpheniramine + Menthol + Phenylephrine + Ambroxol + Guaifenesin safe during breastfeeding?
If you are breastfeeding, you may experience some harmful effects of Chlorpheniramine + Menthol + Phenylephrine + Ambroxol + Guaifenesin. In case you experience any of these, discontinue its use until you consult your doctor.
What is the effect of Chlorpheniramine + Menthol + Phenylephrine + Ambroxol + Guaifenesin on the Kidneys?
Chlorpheniramine + Menthol + Phenylephrine + Ambroxol + Guaifenesin is completely safe for kidneys.
What is the effect of Chlorpheniramine + Menthol + Phenylephrine + Ambroxol + Guaifenesin on the Liver?
Chlorpheniramine + Menthol + Phenylephrine + Ambroxol + Guaifenesin is not harmful for the liver.
What is the effect of Chlorpheniramine + Menthol + Phenylephrine + Ambroxol + Guaifenesin on the Heart?
Using Chlorpheniramine + Menthol + Phenylephrine + Ambroxol + Guaifenesin does not have any harmful effects on the heart.
Chlorpheniramine + Menthol + Phenylephrine + Ambroxol + Guaifenesin should not be taken with following medicines due to severe side effects it may cause to patients -
Severe
Moderate
If you are suffering from any of the following diseases, you should not take Chlorpheniramine + Menthol + Phenylephrine + Ambroxol + Guaifenesin unless your doctor advises you to do so -
Is this Chlorpheniramine + Menthol + Phenylephrine + Ambroxol + Guaifenesin habit forming or addictive?
Forming a habit of Chlorpheniramine + Menthol + Phenylephrine + Ambroxol + Guaifenesin has not been reported.
Interaction between Food and Chlorpheniramine + Menthol + Phenylephrine + Ambroxol + Guaifenesin
Taking Chlorpheniramine + Menthol + Phenylephrine + Ambroxol + Guaifenesin with food is safe.
Interaction between Alcohol and Chlorpheniramine + Menthol + Phenylephrine + Ambroxol + Guaifenesin
No research has been done on this till date. Therefore, it is not known what the effect of taking Chlorpheniramine + Menthol + Phenylephrine + Ambroxol + Guaifenesin with alcohol will be.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 164,165
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 888
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Vazculep (phenylephrine hydrochloride)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 135-136
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 1020-1022
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 219
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Guaifenesin
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 629-631